Expression of thrombospondin in TGFβ-treated APCs and its relevance to their immune deviation-promoting properties

Journal of Immunology

Volumn 168, Issue 5, 2002, Pages 2264-2273

  Masli, Sharmila ^a   Turpie, Bruce ^a   Hecker, Karl H ^a   Streilein, J Wayne ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD40 ANTIGEN; INTERLEUKIN 12; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 2; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; CYTOKINE; GAMMA INTERFERON; HISTOCOMPATIBILITY ANTIGEN; LEUKOCYTE ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HYBRIDOMA CELL CULTURE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; HYBRIDOMA; IMMUNOLOGY; MACROPHAGE; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; CYTOKINES; GENE EXPRESSION PROFILING; HISTOCOMPATIBILITY ANTIGENS; HYBRIDOMAS; INTERFERON TYPE II; INTERLEUKIN-12; MACROPHAGES; MICE; MODELS, IMMUNOLOGICAL; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SELF TOLERANCE; THROMBOSPONDINS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

EID: 0036489182     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.5.2264     Document Type: Article

References (41)

1. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens
2. Immune privilege extended to allogeneic tumor cells in the vitreous cavity
3. Analysis of immune deviation elicited by antigens injected into the subretinal space
4. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β
5. Studies on the induction of anterior chamber-associated immune deviation (ACAID). I. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood
6. Studies on the induction of anterior chamber associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood borne signals that induce ACAID
7. Macrophages capable of inducing anterior chamber associated immune deivation demonstrate spleen-seeking migratory properties
8. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
9. MIP-2 recruits NKT cells to the spleen during tolerance induction
10. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye
11. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type
12. Studies on the induction of anterior chamber associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β
13. TGF-β promotes immune deviation by altering accessory signals of APCs
14. Functional analysis of macrophage hybridomas. I. Production and initial characterization
15. Functional analysis of cloned macrophage hybridomas. VI. Differential ability to induce immunity or suppression
16. Distinct roles for transforming growth factor-β2 and tumour necrosis factor-α in immune deviation elicited by hapten-derivatized antigen-presenting cells
17. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
18. RNA fingerprinting using arbitrarily primed PCR identifies differentially regulated RNAs in mink lung (MvILu) cells growth arrested by transforming growth factor β1
19. Interactions among regulators of RNA abundance characterized using RNA fingerprinting by arbitrarily primed PCR
20. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance
21. In-vivo impaired T helper I cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye
22. Functional interaction between TGF-β and IL-12 in human primary allogeneic cytotoxicity and proliferative response
23. Regulation of microglial activation by TGF-β, IL-10, and CSF-1
24. CD40/CD40 ligand interactions are required for T cell-dependent production of in terleukin-12 by mouse macrophages
25. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40
26. IFN-β differentially regulates CD40-induced cytokine secretion by human dendritic cells
27. CD47 ligation selectively down-regulates human interleukin 12 production
28. On the mechanisms by which transforming growth factor-β2 alters antigen-presenting abilities of macrophages on T cell activation
29. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-κB
30. NF-κB: A key role in inflammatory diseases
31. Antagonistic effect of IFN-β on the IFN-γ-induced expression of Ia antigen in murine macrophages
32. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection
33. + T cells
34. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1
35. Thrombospondin-1 is a major activator of TGF-β1 in vivo
36. Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36
37. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFβ2-treated antigen presenting cells
38. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin
39. Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation
40. + T cells in the long-term culture of murine tumour-infiltrating lymphocytes: A possible role of transforming growth factor-β
41. Regulation of NK cell functions by TGF-β1